{"id":"https://openalex.org/W2898020169","doi":"https://doi.org/10.1186/s13023-018-0930-3","title":"Investigating the landscape of US orphan product approvals","display_name":"Investigating the landscape of US orphan product approvals","publication_year":2018,"publication_date":"2018-10-22","ids":{"openalex":"https://openalex.org/W2898020169","doi":"https://doi.org/10.1186/s13023-018-0930-3","mag":"2898020169","pmid":"https://pubmed.ncbi.nlm.nih.gov/30348193","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6198498"},"language":"en","primary_location":{"id":"doi:10.1186/s13023-018-0930-3","doi":"https://doi.org/10.1186/s13023-018-0930-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-018-0930-3","pdf_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-018-0930-3","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-018-0930-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053849238","display_name":"Kathleen L. Miller","orcid":"https://orcid.org/0000-0002-3939-3660","observed_orcids":["https://orcid.org/0000-0002-3939-3660"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kathleen L. Miller","raw_affiliation_strings":["Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, USA. Kathleen.miller@fda.hhs.gov","Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, USA. Kathleen.miller@fda.hhs.gov","institution_ids":["https://openalex.org/I1320320070"]},{"raw_affiliation_string":"Office of Orphan Products Development, Office of the Commissioner, US Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20903, USA","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052998210","display_name":"Michael L. Lanthier","orcid":"https://orcid.org/0000-0001-9673-2852","observed_orcids":["https://orcid.org/0000-0001-9673-2852"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Lanthier","raw_affiliation_strings":["Office of Planning, Office of the Commissioner, US Food and Drug Administration, Silver Spring, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of Planning, Office of the Commissioner, US Food and Drug Administration, Silver Spring, USA","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5053849238"],"corresponding_institution_ids":["https://openalex.org/I1320320070"],"apc_list":{"value":2990,"currency":"USD","value_usd":2990},"apc_paid":{"value":2990,"currency":"USD","value_usd":2990},"fwci":9.428,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.97816081,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"13","issue":"1","first_page":"183","last_page":"183"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orphan-drug-act","display_name":"Orphan Drug Act","score":0.9959999918937683},{"id":"https://openalex.org/keywords/orphan-drug-approval","display_name":"orphan drug approval","score":0.6899999976158142},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.9769999980926514},{"id":"https://openalex.org/keywords/orphan-drug-designation","display_name":"orphan drug designation","score":0.6539999842643738},{"id":"https://openalex.org/keywords/new-chemical-entities","display_name":"new chemical entities","score":0.9409999847412109},{"id":"https://openalex.org/keywords/new-formulations","display_name":"new formulations","score":0.6990000009536743},{"id":"https://openalex.org/keywords/priority-review","display_name":"priority review","score":0.8009999990463257},{"id":"https://openalex.org/keywords/biologic-drugs","display_name":"biologic drugs","score":0.8379999995231628},{"id":"https://openalex.org/keywords/small-molecule-drugs","display_name":"small molecule drugs","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-development-policy","display_name":"drug development policy","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.9846781492233276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6942682266235352},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.5872923135757446},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5061187148094177},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.436341255903244},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42666566371917725},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30785852670669556},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2028561532497406},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12279751896858215},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s13023-018-0930-3","doi":"https://doi.org/10.1186/s13023-018-0930-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-018-0930-3","pdf_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-018-0930-3","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5159210","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6198498","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6198498","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6198498","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet J Rare Dis","raw_type":"Text"},{"id":"pmid:30348193","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30348193","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet journal of rare diseases","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:999b727b54c24e4997088baf5cabb9b0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/999b727b54c24e4997088baf5cabb9b0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-8 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13023-018-0930-3","doi":"https://doi.org/10.1186/s13023-018-0930-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13023-018-0930-3","pdf_url":"https://ojrd.biomedcentral.com/track/pdf/10.1186/s13023-018-0930-3","source":{"id":"https://openalex.org/S71291065","display_name":"Orphanet Journal of Rare Diseases","issn_l":"1750-1172","issn":["1750-1172"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Orphanet Journal of Rare Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2898020169.pdf","grobid_xml":"https://content.openalex.org/works/W2898020169.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2019375534","https://openalex.org/W2024559544","https://openalex.org/W2025971693","https://openalex.org/W2035802792","https://openalex.org/W2036132972","https://openalex.org/W2054519060","https://openalex.org/W2059992865","https://openalex.org/W2104505549","https://openalex.org/W2118820600","https://openalex.org/W2123407823","https://openalex.org/W2294423247","https://openalex.org/W2571094594","https://openalex.org/W2770849724"],"related_works":["https://openalex.org/W2043764211","https://openalex.org/W2024559544","https://openalex.org/W2282741521","https://openalex.org/W4283517765","https://openalex.org/W4291910309","https://openalex.org/W4390660638","https://openalex.org/W4381839562","https://openalex.org/W3172587796","https://openalex.org/W2111957622","https://openalex.org/W4317233758"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,120],"Orphan":[2,63,246],"Drug":[3,64,247],"Act":[4,28,65,248],"was":[5],"enacted":[6],"in":[7,143,158,173,197,285],"1983":[8],"to":[9,22,250],"encourage":[10],"the":[11,24,27,32,42,59,62,82,85,90,112,124,137,144,156,174,205,229,245,279],"development":[12,255],"of":[13,26,34,44,58,61,70,81,89,126,149,176,207,220,231,261,278],"drugs":[14,47,100,209,297],"for":[15,49,103,128,163,256,302],"rare":[16,105,257,280],"diseases.":[17,258],"Previous":[18],"research":[19],"has":[20,131,152,192,212,237,272],"attempted":[21],"examine":[23],"impact":[25],"by":[29,66,155],"assessing":[30],"either":[31],"number":[33,43,125,175],"orphan":[35,46,75,93,129,232,262],"designations":[36],"that":[37,123,183,204,244],"have":[38,169,187,224,251,264,287],"been":[39,132,153,171,188,194,265,288],"granted":[40],"or":[41],"new":[45,96,117,178,296],"approved":[48,101,114,162,165,177,211],"marketing.":[50],"This":[51,269],"study":[52],"provides":[53],"a":[54,104,275],"more":[55],"in-depth":[56],"understanding":[57],"effect":[60,271],"investigating":[67],"all":[68],"types":[69,294],"drug":[71,222,254],"approvals":[72,94,127,233,260,286],"with":[73,78],"an":[74,195],"designation,":[76],"along":[77],"multiple":[79],"characteristics":[80],"drugs,":[83,166],"over":[84,134,214,227,267],"entire":[86],"35":[87],"years":[88],"Act.":[91],"These":[92],"include:":[95],"molecular":[97],"entities":[98],"(new":[99],"first":[102,113],"disease),":[106],"secondary":[107,159,299],"indications":[108,130,160,186,263],"(an":[109],"expansion":[110],"from":[111],"indication),":[115],"and":[116,136,298,301,305],"formulations.":[118],"RESULTS:":[119],"results":[121],"show":[122],"increasing":[133,189,266,270],"time,":[135,228],"upward":[138],"trend":[139],"is":[140],"especially":[141],"large":[142],"most":[145],"recent":[146],"years.":[147],"Much":[148],"this":[150,221],"increase":[151,157,196],"driven":[154],"being":[161,210],"previously":[164],"although":[167],"there":[168,191],"also":[170,181,193],"increases":[172],"drugs.":[179,308],"We":[180],"find":[182,203],"while":[184,217],"oncology":[185],"significantly,":[190],"other":[198,218],"therapeutic":[199,291],"areas.":[200],"Additionally,":[201,259],"we":[202],"proportion":[206,230],"biologic":[208],"increased":[213],"time.":[215,268],"Lastly,":[216],"parts":[219],"landscape":[223],"dramatically":[225],"altered":[226],"receiving":[234],"priority":[235],"review":[236],"not":[238,273],"changed.":[239],"CONCLUSIONS:":[240],"Our":[241],"data":[242],"suggest":[243],"appears":[249],"stimulated":[252],"significant":[253],"targeted":[274],"single":[276],"area":[277],"disease":[281],"space,":[282],"rather,":[283],"gains":[284],"seen":[289],"across:":[290],"areas,":[292],"approval":[293],"(both":[295],"indications),":[300],"both":[303],"biologics":[304],"small":[306],"molecule":[307]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-10-26T00:00:00"}